AI assistant
Sending…
MedservRegis Plc — AGM Information 2015
May 28, 2015
2071_rns_2015-05-28_832a77d6-8da3-447e-b914-c51c20cd3c03.pdf
AGM Information
Open in viewerOpens in your device viewer

COMPANY ANNOUNCEMENT
MEDSERV PLC (THE "COMPANY")
Announces the outcome of the resolutions proposed to the annual general meeting.
| Date of Announcement | 28 May 2015 |
|---|---|
| Reference | 116/2015 |
| Listing Rule | LR5.16.18 |
This is a company announcement being made by the Company in compliance with Chapter 5 of the Listing Rules:
Annual General Meeting
At the annual general meeting of the Company held on the 28 May 2015, the shareholders considered and approved the following resolutions:
Ordinary Business
Resolutions
-
- that the Consolidated Financial Statements for the financial period ended 31 December 2014 and the Directors' and Auditors' report thereon be hereby received and approved;
-
- that the appointment of KPMG as auditors of the company be hereby approved and that the Board of Directors be hereby authorized to fix their remuneration;
-
- that a net dividend per ordinary share of €0.056 equivalent to the sum of €1,400,000 as recommended by the Directors, be and is hereby approved for payment to all shareholders on the register of members as at the close of trading on the 28 May 2015.
The Company had five vacancies for Directors. Five valid nominations have been received with respect to Anthony J. Duncan, Anthony S. Diacono, Charles Daly, Joseph F.X. Zahra and Joseph Zammit Tabona. In view of the fact that there were as many nominations as there were vacancies on the board, the nominated persons were automatically appointed directors.
Signed:
________________________ Louis de Gabriele
Company Secretary
More from MedservRegis Plc
Interim / Quarterly Report
2026
May 22
Board/Management Information
2026
May 11
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Apr 22
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 30
Capital/Financing Update
2026
Feb 5
Report Publication Announcement
2026
Jan 26
Capital/Financing Update
2026
Jan 21
Regulatory Filings
2026
Jan 12